The effectiveness of the varicella vaccine in clinical practice

New England Journal of Medicine

Volumn 344, Issue 13, 2001, Pages 955-960

  Vázquez, Marietta ^a   Larussa, Phillip S ^b   Gershon, Anne A ^b   Steinberg, Sharon P ^b   Freudigman, Kimberly ^b   Shapiro, Eugene D ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE;

ADOLESCENT; ARTICLE; CHICKENPOX; CHILD; CLINICAL PRACTICE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UNITED STATES; VARICELLA ZOSTER VIRUS;

ADOLESCENT; CASE-CONTROL STUDIES; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; FEMALE; HERPESVIRUS 3, HUMAN; HUMANS; INFANT; MALE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0035967233     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200103293441302     Document Type: Article

References (21)

1. Live vaccine used to prevent the spread of varicella in children in hospital
2. Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
3. Varicella immunization practices and the factors that influence them
4. Resolving the pneumococcal vaccine controversy: Are there alternatives to randomized clinical trials?
5. Live attenuated varicella virus vaccine: Efficacy trial in healthy children
6. Live Oka/Merck varicella vaccine in healthy children: Further clinical and laboratory assessment
7. Live attenuated varicella vaccine: Efficacy for children with leukemia in remission
8. A long-term prospective study of varicella vaccine in healthy children
9. Oka/Merck varicella vaccine in healthy children: Final report of a 2-year efficacy study and 7-year follow-up studies
10. Over five-year follow-up of Oka/Merck varicella vaccine recipients in 465 infants and adolescents
11. Experience and reason: Twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine
12. Varicella vaccine: The Japanese experience
13. Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates
14. Decline in varicella disease: Evidence of vaccine impact
15. Postlicensure effectiveness of varicella vaccine during an outbreak in a child care center
16. Varicella outbreaks after vaccine licensure: Should they make you chicken?
17. Postlicensure study of varicella vaccine effectiveness in a day-care setting